RE: Cocrystal Pharma $6.9 million arbitration case against HVIVO2 Apr 2026 22:12
You mght want to listen to the Vox Markets podcast. There is a view from a couple of fund managers that Iliad appear to be in the process of renegotiating the terms of the contract - the environment when the LOI was signed is different today in terms of the demand supply function within the CRO industry i.e. there is a lot of spare capacity for trials now than before. With that in mind, if terms are agreed, I believe this will be at a noticably lower price than what was originally communicated to the market. I would expect this to be around the US$8m mark. If this is the case, I don't see much uplift if any in the current share price, compared to what we saw a month or so ago. Just my opinion, you are entitled to your own.
DYOR